Top Midday Gainers

MT Newswires Live

Oct 17

Praxis Precision Medicines (PRAX) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.

Shares surged nearly 200% as intraday trading volume catapulted to over 11.9 million from a daily average of about 466,000.

Mira Pharmaceuticals (MIRA) said Thursday that new preclinical data showed oral administration of marijuana analog Mira-55 provided "superior" pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain.

Shares surged 42% as intraday trading volume soared to over 102.5 million from a daily average of roughly 1.2 million.

Apollomics (APLM) said late Wednesday that it received a letter from Nasdaq stating that the company is compliant with the stock exchange's continued listing requirements.

Shares soared 45% as intraday trading volume rose to more than 216,000 from a daily average of about 53,000.

Price: 170.68, Change: +113.33, Percent Change: +197.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2576333722"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576333722\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576333722?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 02:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576333722","market":"nz","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PRAX\">Praxis Precision Medicines</a> (PRAX) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.</p><p>Shares surged nearly 200% as intraday trading volume catapulted to over 11.9 million from a daily average of about 466,000.</p><p>Mira Pharmaceuticals (MIRA) said Thursday that new preclinical data showed oral administration of marijuana analog Mira-55 provided \"superior\" pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain.</p><p>Shares surged 42% as intraday trading volume soared to over 102.5 million from a daily average of roughly 1.2 million.</p><p><a href=\"https://laohu8.com/S/APLMW\">Apollomics</a> (APLM) said late Wednesday that it received a letter from Nasdaq stating that the company is compliant with the stock exchange's continued listing requirements.</p><p>Shares soared 45% as intraday trading volume rose to more than 216,000 from a daily average of about 53,000.</p><p>Price: 170.68, Change: +113.33, Percent Change: +197.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-17 02:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PRAX\">Praxis Precision Medicines</a> (PRAX) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.</p><p>Shares surged nearly 200% as intraday trading volume catapulted to over 11.9 million from a daily average of about 466,000.</p><p>Mira Pharmaceuticals (MIRA) said Thursday that new preclinical data showed oral administration of marijuana analog Mira-55 provided \"superior\" pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain.</p><p>Shares surged 42% as intraday trading volume soared to over 102.5 million from a daily average of roughly 1.2 million.</p><p><a href=\"https://laohu8.com/S/APLMW\">Apollomics</a> (APLM) said late Wednesday that it received a letter from Nasdaq stating that the company is compliant with the stock exchange's continued listing requirements.</p><p>Shares soared 45% as intraday trading volume rose to more than 216,000 from a daily average of about 53,000.</p><p>Price: 170.68, Change: +113.33, Percent Change: +197.61</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLM","symbol_name":"Apollomics Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2576333722","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2576333722","pubTimestamp":1760638967,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Praxis Precision Medicines (PRAX) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.Shares surged nearly 200% as intraday tradi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APLM":"Apollomics Inc","PRAX":"Praxis Precision Medicines, Inc.","BK4139":"生物科技","BK4007":"制药","MIRA":"Mira Pharma"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLM":1,"MIRA":1,"PRAX":1},"content_text":"Praxis Precision Medicines (PRAX) said two phase 3 trials of its investigational drug ulixacaltamide in essential tremor met primary and secondary endpoints.Shares surged nearly 200% as intraday trading volume catapulted to over 11.9 million from a daily average of about 466,000.Mira Pharmaceuticals (MIRA) said Thursday that new preclinical data showed oral administration of marijuana analog Mira-55 provided \"superior\" pain normalization and significantly reduced inflammation, outperforming injected morphine in an established animal model of inflammatory pain.Shares surged 42% as intraday trading volume soared to over 102.5 million from a daily average of roughly 1.2 million.Apollomics (APLM) said late Wednesday that it received a letter from Nasdaq stating that the company is compliant with the stock exchange's continued listing requirements.Shares soared 45% as intraday trading volume rose to more than 216,000 from a daily average of about 53,000.Price: 170.68, Change: +113.33, Percent Change: +197.61","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}